tiprankstipranks
Analyst Profile
Followed by 676 other investors
.
Michael Yee

Michael Yee

Jefferies
Wall Street Analyst
Ranked #6,607 out of 8,047 Analysts on TipRanks (#17,631 out of 21,521 overall experts)

Success Rate

45%
158 out of 350 Profitable Transactions

Average Return

-1.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Michael Yee's ratings since 2012 and opened each position for the duration of 1 Year:
45.14% of your transactions would have been profitable with an average return of -1.4%

Stock Rating Distribution

1KRatings
82.83% Buy
16.76% Hold
0.41% Sell
Distribution of Michael Yee's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Beam Therapeutics, Inc.
(BEAM)
Rating Type:Buy
Dates:Mar 02, 2020 - Mar 02, 2021
Gain:300.90%
The most profitable rating made by Michael Yee

Michael Yee's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Myrexis
Buy
Reiterated
$28.00
(6999900.00% Upside)
0.00%
2
Oracle
Buy
Upgraded
0.00%
1
Uni-Pixel
Buy
Reiterated
0.00%
1
Elan Corp
Hold
Reiterated
0.00%
3
Astex Pharmaceuticals
Buy
Reiterated
0.00%
3
Dendreon Corp
Hold
Reiterated
0.00%
2
Myriad Genetics
Hold
Assigned
$40.00
(44.88% Upside)
0.00%
4
InterMune
Hold
Assigned
0.00%
3
Auxilium
Hold
Downgraded
0.00%
9
Pharmacyclics
Hold
Reiterated
0.00%
13
List of latest recommendations made by Michael Yee. Click to expand and see Michael Yee's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More